TALPHERA, INC. Income Taxes Disclosure
14. Income Taxes
The Company did not accrue or pay any income taxes in the years ended December 31, 2025 or 2024.
Net deferred tax assets as of December 31, 2025 and 2024, consist of the following (in thousands):
|
December 31, |
December 31, |
|||||||
|
Deferred tax assets: |
||||||||
|
Accruals and other |
$ | 1,854 | $ | 1,347 | ||||
|
Research credits |
3,006 | 8,379 | ||||||
|
Net operating loss carryforward |
63,733 | 90,142 | ||||||
|
Section 59(e) R&D expenditures |
2,763 | 1,136 | ||||||
|
Section 174 R&D expenditures |
1,780 | 2,446 | ||||||
|
XOMA royalty |
1,819 | 1,371 | ||||||
|
Total deferred tax assets |
74,955 | 104,821 | ||||||
|
Deferred tax liabilities: |
||||||||
|
IP from acquisition |
(2,468 | ) | (1,852 | ) | ||||
|
Total deferred tax liabilities |
(2,468 | ) | (1,852 | ) | ||||
|
Valuation allowance |
(72,487 | ) | (102,969 | ) | ||||
|
Net deferred tax assets |
$ | — | $ | — | ||||
The Company adopted ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures prospectively, as disclosed in Note 1. The following is a reconciliation between the provision for income taxes and income taxes computed using the U.S. federal statutory corporate tax rate for the year ended December 31, 2025, in accordance with the new disclosure requirements (in thousands):
|
Year Ended December 31, 2025 |
||||||||
|
Amount |
Percent | |||||||
|
Tax at statutory federal rate |
$ | (3,001 | ) | 21 | % | |||
|
State tax—net of federal benefit |
- | 0 | % | |||||
|
Research credits |
(93 | ) | 1 | % | ||||
|
Stock options |
266 | (2 | )% | |||||
|
Other |
(89 | ) | 1 | % | ||||
|
Change in valuation allowance |
(24,439 | ) | 171 | % | ||||
|
Revaluation of put option liability |
276 | (2 | )% | |||||
|
Expiration of NOL’s/credits due to ownership change |
27,080 | (190 | )% | |||||
|
Provision for income taxes |
$ | - | 0 | % | ||||
The following is a reconciliation between the provision for income taxes and income taxes computed using the U.S. federal statutory corporate tax rate for the year ended December 31, 2024, in accordance with the guidance prior to the adoption of ASU 2023-09 (in thousands):
|
Year Ended December 31, 2024 |
||||
|
Tax at statutory federal rate |
$ | (2,731 | ) | |
|
State tax—net of federal benefit |
55 | |||
|
Research credits |
(363 | ) | ||
|
Stock options |
319 | |||
|
Other |
10 | |||
|
Change in valuation allowance |
2,860 | |||
|
Revaluation of put option liability |
(150 | ) | ||
|
Expiration of NOL’s/credits due to ownership change |
— | |||
|
Provision for income taxes |
$ | — | ||
ASC 740 requires that the tax benefit of net operating losses, temporary differences and credit carryforwards be recorded as an asset to the extent that management assesses that realization is “more likely than not.” Realization of deferred tax assets is dependent on future taxable income, if any, the timing and the amount of which are uncertain. Accordingly, the deferred tax assets have been fully offset by a valuation allowance. The valuation allowance decreased by $30.5 million and increased by $2.9 million during the years ended December 31, 2025 and 2024, respectively.
As of December 31, 2025, the Company had federal net operating loss carryforwards of $295.9 million, of which $12.7 million federal net operating losses generated before January 1, 2018, will begin to expire in 2029. Federal net operating losses of $283.2 million generated from 2018 to 2025, will carryforward indefinitely but are subject to the 80% taxable income limitation. As of December 31, 2025, the Company had state net operating loss carryforwards of $23.0 million, which begin to expire in 2028.
As of December 31, 2025, the Company had federal research credit carryovers of $0.1 million, which begin to expire in 2045. As of December 31, 2025, the Company had state research credit carryovers of $4.9 million, which will carryforward indefinitely.
Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an “ownership change,” generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the corporation’s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes, such as research credits, to offset its post-change income may be limited. Based on an analysis performed by the Company as of December 31, 2025, an ownership change occurred September 10, 2025. The ownership change results in an annual limitation of approximately $1.7 million for the first five years after the change, and a limitation of approximately $0.6 million thereafter for federal net operating loss carryforwards, and a limitation of approximately $0.6 million annually for California net operating loss carryforwards. As a result of the change, approximately $102.2 million in federal net operating loss carryforwards approximately $119.6 million of California net operating loss carryforwards, and approximately $7.5 million of federal research and development credit carryforwards will expire unutilized.
Uncertain Tax Positions
A reconciliation of the beginning and ending balances of the unrecognized tax benefits during the years ended December 31, 2025 and 2024, is as follows (in thousands):
|
Year Ended December 31, |
||||||||
|
2025 |
2024 | |||||||
|
Unrecognized benefit—beginning of period |
$ | 3,031 | $ | 2,835 | ||||
|
Gross decrease—NOL’s/credits limitation |
(1,753 | ) | — | |||||
|
Gross increases—current period tax positions |
97 | 196 | ||||||
|
Unrecognized benefit—end of period |
$ | 1,375 | $ | 3,031 | ||||
The entire amount of the unrecognized tax benefits would not impact the Company’s effective tax rate if recognized.
There were accrued interest or penalties related to unrecognized tax benefits in the years ended December 31, 2025 or 2024. The Company files income tax returns in the United States, California, and other states. The tax years through 2014, and 2016 through 2025, remain open in all jurisdictions. The Company is not currently under examination by income tax authorities in U.S. federal, state or foreign jurisdictions. The Company does not anticipate any significant changes within 12 months of this reporting date of its uncertain tax positions.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 23, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Mar 6, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Mar 10, 2022 | |
| 2020 | Mar 15, 2021 | |
| 2019 | Mar 16, 2020 | |
| 2018 | Mar 7, 2019 | |
| 2017 | Mar 9, 2018 | |
| 2016 | Mar 3, 2017 | |
| 2015 | Mar 7, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.